What's new this week?

Read about a new 24-hour sterility testing method and the securing of renewable energy in key manufacturing markets. You can also listen to our new podcast focusing on biosimilars development.

Interested in the future of mRNA therapies? Check out our video below with Nicolas Chornet ! You can also download the new whitepaper highlighting the value and benefits of rapid mould detection within a day, or the application note comparing bacterial and fungi detection performance.

Trending news from the industry:

Innovative technologies facilitate novel contamination-detection method

A new 24-hour sterility testing method combining nanopore sequencing and machine learning could revolutionise sterility assurance in biopharmaceutical manufacturing of cell therapies. Read more here.

Pharma unites to secure renewable energy in key manufacturing markets

For the first time, companies across the global healthcare sector, including 阿斯利康 , 荷商葛蘭素史克藥廠 , 诺和诺德 and 罗氏公司 , have united to discuss with energy providers in China and India, about scaling renewable power across their supply chains. This step is important as these countries are key markets for pharmaceuticals manufacturing. Read more here.

What to read:

This whitepaper highlights the value and benefits of rapid mould detection within a day, emphasises the importance of accurate microbial identifications and the significance of performing quality control disinfection protocols. Read more here.

Learn from the authors as they compare the bacterial and fungal detection performance of the Microsart ATMP Bacteria and Microsart ATMP Fungi detection kits and the compendial method. They'll share their results, findings and recommendations in this application note.

What to listen to:

In this latest podcast, Dr Salim Benkhalifa , Medical Affairs Lead, Celltrion Healthcare France , reflects on biosimilars development, highlighting the three core challenges facing the sector and how they might be overcome. Listen now.

What to watch:

Nicolas Chornet , Senior Vice President of International Manufacturing at Moderna , speaks to EPR about the future of mRNA therapies and offers an update on the company’s international expansion plans.

Missed our live webinars? Don't worry - you can still catch all of the key information, findings and recommendations on our on-demand webinars.

Watch this webinar to learn how continuous flow manufacturing can support the capable handling of dangerous chemicals. Register here.

Brought to you by ThermoFisher Scientific , watch this webinar to learn how to overcome the most common challenges in HPAPI handling. Register now.

European Pharmaceutical Review is an essential resource for students, researchers and industry professionals looking for the latest industry insights and innovations. Sign up for free now.